La autopsia molecular en la muerte súbita cardiaca
Author(s) -
Juan Carlos Leiva,
Rafael ParraMedina,
Juan José Cháves,
Óscar Campuzano,
Geòrgia Sarquella-Brugada,
Ramón Brugada,
Josép Brugada
Publication year - 2018
Publication title -
archivos de cardiología de méxico
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.149
H-Index - 17
eISSN - 1405-9940
pISSN - 1665-1731
DOI - 10.1016/j.acmx.2018.06.001
Subject(s) - catecholaminergic polymorphic ventricular tachycardia , medicine , brugada syndrome , sudden death , long qt syndrome , short qt syndrome , cause of death , sudden cardiac death , autopsy , disease , cardiology , qt interval , ryanodine receptor 2 , ryanodine receptor , calcium
Currently, there are a significant percentage of autopsies left without a conclusive diagnosis of death, especially when this lethal event occurs suddenly. Genetic analysis has been recently incorporated into the field of forensic medicine, especially in patients with sudden death and where no conclusive cause of death is identified after a complete medical-legal autopsy. Inherited arrhythmogenic diseases are the main cause of death in these cases. To date, more than 40 genes have been associated with arrhythmogenic disease, and causing sudden cardiac death has been described. The main arrhythmogenic diseases are Long QT Syndrome, Catecholaminergic Polymorphic Ventricular Tachycardia, Brugada Syndrome, and Short QT Syndrome. These post-mortem genetic studies, not only allow a diagnosis of the cause of death, but also allow a clinical translation in relatives, focusing on the early identification of individuals at risk of syncope, as well as adopting personalised therapeutic measures for the prevention of a lethal arrhythmic episode.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom